Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 | Sensenig BethanyDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 2,989 sh | Nov 4, 2026 |
| 8 | Baszucki GregoryDirector |  RBLXRoblox CorpOpen-market sale · 10b5-1 plan | SELL | $204K 4,481 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 8 | Hall John TDirector, Chief Executive Officer |  INTAIntapp, Inc.Open-market sale · 10b5-1 plan | SELL | $14K 300 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Horich William ToddSVP, Commercial Operations | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 17.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $18K 379 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Baszucki GregoryDirector | RBLXRoblox Corp Open-market sale · 10b5-1 plan | SELL | $204K 4,485 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 8 | Watkins PhilipEVP, Head of Corp Devel & IR |  CUBICustomers Bancorp, Inc.Option exercise | M | $57K 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Sensenig BethanyDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 7,296 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 8 | Vecchio JenniferGroup President and CMO |  BURLBurlington Stores, Inc.Open-market sale · 10b5-1 plan | SELL | $132K 555 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 7 | Tsuchimoto Kim RDirector |  MNPRMonopar TherapeuticsOption exercise · 10b5-1 plan | M | $28K 2,035 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 7 | Comly Barbara J.EVP, GC & Corporate Secretary | MIAXMIAMI INTERNATIONAL HOLDINGS, INC. Option exercise · 10b5-1 plan | M | — 47.2K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 7 | Tsuchimoto Kim RDirector | MNPRMonopar Therapeutics Option exercise · 10b5-1 plan | M | — 1,199 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 7 | Tsuchimoto Kim RDirector | MNPRMonopar Therapeutics Option exercise · 10b5-1 plan | M | — 2,035 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 7 | Anderson RaymondDirector | MNPRMonopar Therapeutics Option exercise · 10b5-1 plan | M | $42K 1,402 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 7 | Maetzold Derek JDirector, Pres. & Chief Exec. Officer |  CSTLCASTLE BIOSCIENCES INCOpen-market sale · 10b5-1 plan | SELL | $14K 382 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 7 | Maetzold Derek JDirector, Pres. & Chief Exec. Officer | CSTLCASTLE BIOSCIENCES INC Open-market sale · 10b5-1 plan | SELL | $12K 325 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 7 | Bayview Legacy, LLC10% Owner |  AIPArteris, Inc.Open-market sale · 10b5-1 plan | SELL | $1.73M 95.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 7 | Wassenaar YvonneDirector | RBRKRubrik, Inc. Derivative conversion · 10b5-1 plan | C | — 721 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 7 | Zage George Raymond IIIDirector, 10% Owner |  GRNDGrindr Inc.Open-market sale · 10b5-1 plan | SELL | $2.22M 170.0K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 7 | Tang StanleyDirector | DASHDoorDash, Inc. Other acquisition or disposition · 10b5-1 plan | J | — 23.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 7 | Zage George Raymond IIIDirector, 10% Owner | GRNDGrindr Inc. Open-market sale · 10b5-1 plan | SELL | $4.22M 330.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $126K 403 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER |  MIRMMirum Pharmaceuticals, Inc.Option exercise · 10b5-1 plan | M | $59K 20.0K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 6 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $155K 1,328 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $229K 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $102K 320 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $162K 520 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $192K 774 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $227K 933 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $64K 200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $121K 480 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $225K 920 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $152K 490 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $198K 634 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Amara CarmenChief People Officer |  YELPYELP INCOpen-market sale · 10b5-1 plan | SELL | $9,605 500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $84K 699 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $218K 708 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $145K 1,262 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $123K 1,064 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 6 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $91K 500 sh | Nov 4, 2026 traded Nov 2, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
MTDRMatador Resources CoNov 5 – Nov 56 insiders$507K
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K